Papers Published:
- Gokulnath Mahalingam, Nikunj Tandel, Rajeev K Tyagi, Srujan Marepally* Engineering natural killer cells with lipid nanoparticle enabled IL-2 mRNA transfection: Steps towards affordable precision immuno-therapeutics. Molecular Therapy-Nucleic Acids 2024, 35, 102276.
- In Press, Journal Pre-proof
Varun Katta, Kiera O’Keefe, Yichao Li, Thiyagaraj Mayurathan, Cicera R. Lazzarotto, Rachael K. Wood, Rachel M. Levine, Alicia Powers, Kalin Mayberry, Garret Manquen, Yu Yao, Jingjing Zhang, Yoonjeong Jang, Nikitha Nimmagadda, Erin A. Dempsey, GaHyun Lee1, Naoya Uchida, Yong Cheng, Frank Fazio, Tim Lockey, Mike Meagher, Akshay Sharma, John F. Tisdale, Sheng Zhou, Jonathan S. Yen1, Mitchell J. Weiss1, Shengdar Q. Tsai. Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease. Molecular Therapy (Jul 28, 2024 Reference: YMTHE 6517 https://doi.org/10.1016/j.ymthe.2024.07.022)
Papers Accepted:
- Porkizhi Arjunan#, Gokulnath Mahalingam#, Priyanka Sankar#, Durga Kathirvelu, Sevanthy Suresh, Sandya Rani, Kumarasamypet M Mohankumar, Saravanabhavan Thangavel, Alok Srivastava, Srujan Marepally* Base-modified Factor VIII mRNA delivery with Galactosylated lipid nanoparticles as a protein replacement therapy for Haemophilia. RSC Biomaterials Science (Accepted on 31st July, 2024)
Event:
- 9th Annual cell and gene therapy symposium held from 1-3 August, 2024. Total participants=835 (794 National (711 virtual+ 83 in-person) + 41 international (40 vitual + 1 in person), 35 international and national speakers and 11 chairpesons
- Hands-On Immunostaining Workshop" 6th and 7th Aug 2024 jointly conducted by CSCR Core Histopathology and Core Imaging facility. Conducted by Dr. Elizabeth Vinod and Dr. Sandya Rani.B, CSCR. No. of participants - 12.
